Publications by authors named "Clay Anderson"

Claim this Profile
M
Multilobular tumor of bone in the mandible of a dog.
Diana L Eubanks, Joel D Ray, Philip A Bushby, Clay Anderson

J Vet Dent· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.
Kazuo Koyanagi, Steven J O'Day, Peter Boasberg, Michael B Atkins, He-Jing Wang, Clay M Anderson

Clin Cancer Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.
Steven J O'Day, Michael B Atkins, Peter Boasberg, He-Jing Wang, John A Thompson, Clay M Anderson

J Clin Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma.
Steven O'Day, Rene Gonzalez, David Lawson, Robert Weber, Laura Hutchins, Clay Anderson

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ellis Fischel Cancer Center needs Missouri's support.
Charles Caldwell, Carl Freter, Clay Anderson

Mo Med· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ellis Fischel Cancer Center: cancer care at the crossroads.
Clay Anderson

Mo Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
Kevin B Kim, Sewa S Legha, Rene Gonzalez, Clay M Anderson, Marcella M Johnson

Melanoma Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative sedation of the dying: ethics and realities.
Clay M Anderson

Mo Med· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
Karl D Lewis, William A Robinson, Martin McCarter, Nathan Pearlman, Steven J O'Day, Clay Anderson

J Clin Oncol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF.
Karl D Lewis, Peter Gibbs, Steven O'Day, Jon Richards, Jeffrey Weber, Clay Anderson

Cancer Invest· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutritional, functional, and emotional characteristics related to fatigue in patients during and after biochemotherapy.
Davina Porock, Brenda Beshears, Pam Hinton, Clay Anderson

Oncol Nurs Forum· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma reporting in Missouri.
Robin Weiner, Clay Anderson, Karen Edison, Erin Greer

Mo Med· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer.
Vikas Malhotra, Victoria J Dorr, Alan P Lyss, Clay M Anderson, Steven Westgate

Clin Breast Cancer· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Close monitoring and lifetime follow-up is optimal for patients with a history of melanoma.
David F Christianson, Clay M Anderson

Semin Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relieving non-pain suffering at the end-of-life.
David D Cravens, Clay M Anderson

Mo Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain relief at the end-of-life: a clinical guide.
Clay M Anderson

Mo Med· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' perceptions of fatigue in response to biochemotherapy for metastatic melanoma: a preliminary study.
Mei R Fu, Clay M Anderson, Roxanne McDaniel, Jane Armer

Oncol Nurs Forum· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
Peter Gibbs, Clay Anderson, Nathan Pearlman, Stacy LaClaire, Maude Becker

Cancer· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis